.jpg&w=3840&q=75)
Featured
Premium
Confidential Source•May 12, 2026
Vicenne Charts an Ambitious Path to 2030: Targeting MAD 1.8B Revenue and Regional Healthcare Dominance
Read More
Market Insights
BOURSSOLE Newsroom
Stay ahead of the market with our curated AI-powered financial news and expert analysis.
7 results for “Vicenne”
Stocks Market
•August 28th, 2026Vicenne Reports 12% Consolidated Revenue Growth in H1 2026, Confirming IPO Targets
Vicenne, a leading African medical equipment provider, delivered a strong first-half performance with consolidated revenue reaching MAD 591 million, up 12% year-over-year. The second quarter saw a 29% surge to MAD 395 million, driven by a 41% jump in the Equipment Business Unit, while the company's ...
Stocks Market
Vicenne Q1 2026 Revenue Slides 11% While 2026 Target Remains Unchanged
boursenews.ma•May 28
Vicenne reported an 11% dip in consolidated revenue for the first quarter of 2026, bringing total sales to MAD 196 million. The decline is driven by a...
Stocks Market
Vicenne Charts an Ambitious Path to 2030: Targeting MAD 1.8B Revenue and Regional Healthcare Dominance
Premium
Confidential Source•May 12
Vicenne is setting its sights on aggressive growth through a 'Buy & Build' strategy, targeting MAD 1.8 billion in revenue and MAD 440 million in EBITD...
Stocks Market
Amethis Fund II Sells 422,000 Vicenne Shares, Cutting 10% Stake Below Target
boursenews.ma•Apr 23
On April 15, 2026, Amethis Fund II SCA SICAR sold 422,000 shares of Morocco’s VC‑backed rare‑earth group Vicenne on the Casablanca Stock Exchange. The...
Stocks Market
Vicenne Beats 2025 Business Plan with 58% Profit Surge
boursenews.ma•Mar 26
In 2025 Vicenne delivered a 58% jump in net profit, surpassing its original business plan. Revenue rose 30% to 1,084 million Dirhams, driven by strong...
Stocks Market
Vicenne Posts 30% Revenue Surge in 2025, Crosses DH1 Billion Milestone
boursenews.ma•Feb 21
Vicenne announced a robust 30 % increase in total 2025 revenue, topping DH 1 billion for the first time. The fourth‑quarter results showed a 39 % jump...
Join 10,000+ Investors
Get the latest market analysis and premium insights delivered to your dashboard.
Create Free Account